Study Protocol for a Randomized Controlled Trial Evaluating the Effectiveness of an Internet-based Self-help Intervention to Cope with Psychological Distress Due to COVID-19 in the Italian General Population: the RinasciMENTE Project
Overview
Pharmacology
Authors
Affiliations
Background: This study aims to evaluate the feasibility and effectiveness of the RinasciMENTE program, an Internet-based self-help intervention based on cognitive behavioral therapy (CBT) principles and techniques in supporting individuals experiencing psychological impairments during the COVID-19 pandemic. A randomized controlled trial (RCT) design with random allocation at the level of individual will be conducted to compare the impact of the RinasciMENTE program with a waiting list control in improving the psychological functioning of the general population during the COVID-19 pandemic.
Methods: A minimum sample of 128 participants experiencing mild/subthreshold levels of psychological symptoms during the COVID-19 pandemic will be recruited. After the initial screening, participants will be randomly assigned to either the experimental group or the control condition. The program will last 2 months, during which participants will receive 8 weekly CBT treatment modules. The impact of the RinasciMENTE program on selected primary and secondary psychological outcomes will be tested at the end of the intervention (2 months) and 6- and 12-month follow-ups.
Discussion: We expect people to show an increased level of psychological functioning and to acquire the skills and self-confidence necessary to deal with the psychological consequences of the COVID-19 outbreak and its related social isolation during and following the pandemic.
Trial Registration: ClinicalTrials.gov NCT0497903 Registered on 28 May 2021.
Semonella M, Marchesi G, Castelnuovo G, Andersson G, Pietrabissa G Digit Health. 2024; 10:20552076241258419.
PMID: 39314812 PMC: 11418310. DOI: 10.1177/20552076241258419.
Validation of the Italian Version of the Web Screening Questionnaire for Common Mental Disorders.
Pietrabissa G, Semonella M, Marchesi G, Mannarini S, Castelnuovo G, Andersson G J Clin Med. 2024; 13(4).
PMID: 38398481 PMC: 10889998. DOI: 10.3390/jcm13041170.
Bertuzzi V, Semonella M, Andersson G, Manzoni G, Castelnuovo G, Molinari E Trials. 2023; 24(1):201.
PMID: 36932452 PMC: 10022985. DOI: 10.1186/s13063-023-07217-z.
Bertuzzi V, Semonella M, Castelnuovo G, Andersson G, Pietrabissa G Int J Environ Res Public Health. 2022; 19(12).
PMID: 35742257 PMC: 9222987. DOI: 10.3390/ijerph19127008.